Ferritinophagy mediated by the AMPK/ULK1 pathway is involved in ferroptosis subsequent to ventilator-induced lung injury
- PMID: 39719634
- PMCID: PMC11669221
- DOI: 10.1186/s12931-024-03076-7
Ferritinophagy mediated by the AMPK/ULK1 pathway is involved in ferroptosis subsequent to ventilator-induced lung injury
Abstract
Mechanical ventilation (MV) remains a cornerstone of critical care; however, its prolonged application can exacerbate lung injury, leading to ventilator-induced lung injury (VILI). Although previous studies have implicated ferroptosis in the pathogenesis of VILI, the underlying mechanisms remain unclear. This study investigated the roles of ferritinophagy in ferroptosis subsequent to VILI. Using C57BL/6J mice and MLE-12 cells, we established both in vivo and in vitro models of VILI and cyclic stretching (CS)-induced cellular injury. We assessed lung injury and the biomarkers of ferroptosis and ferritinophagy, after appropriate pretreatments. This study demonstrated that high tidal volumes (HTV) for 4 h enhanced the sensitivity to ferroptosis in both models, evidenced by increased intracellular iron levels, lipid peroxidation and cell death, which can be mitigated by ferrostatin-1 treatment. Notably, nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy contributed to ferroptosis in VILI. Inhibition of autophagy with 3-methyladenine or NCOA4 knockdown decreased intracellular Fe2+ levels and inhibited lipid peroxidation, thereby attenuating CS-induced lung injury. Furthermore, it has also been observed that the AMPK/ULK1 axis can trigger ferritinophagy in VILI. Collectively, our study indicated that MV can induce ferroptosis by promoting NCOA4-dependent ferritinophagy, which could be a novel therapeutic target for the prevention and treatment of VILI.
Keywords: AMPK-ULK1 axis; Ferritinophagy; Ferroptosis; Ventilation-induced lung injury.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: Animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of Guangxi Medical University Cancer Hospital. Consent to participate: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
MeSH terms
Substances
Grants and funding
- YCSW2024257/Innovation Project of Guangxi Graduate Education
- YQJ2022-4/Youth Program of Scientific Research Foundation of Guangxi Medical Cancer Hospital
- YQJ2023-4/Youth Program of Scientific Research Foundation of Guangxi Medical Cancer Hospital
- GXMUYSF202305/Youth Science Foundation of Guangxi Medical University
- 82100091/The National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
